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Background: HIV testing is encouraged, but in many countries testing is rarely free of charge except 
during campaign periods. Aim: To study experiences from four years of campaign week for HIV-
testing in the town of Ngaoundere, Cameroon. Data have been collected and recorded from hand-
written protocols in 2001, from pre- and post-counselling sheets in 2002, and from laboratory protocols 
in 2003-4. Results: Seropositivity tended to increase with increasing age, female sex, number of sex 
partners last five years and with low educational level. Different dimensions of knowledge about HIV 
was associated with less seropositivity. One of five persons tested never came back to know their result, 
but seropositivity in this group was not higher than for those who returned. Overall HIV prevalence 
during the last three years of campaign testing was 9.0%, a little higher than WHO national figures for 
Cameroon. Conclusions: HIV campaigns including testing may stimulate interest and knowledge about 
HIV, which is important to lower HIV incidence. The HIV vulnerability of females was confirmed. 
Campaigns did not easily attract less educated persons, and campaign testing prevalence therefore could 
be expected to be lower than HIV prevalence in the local population. On the other hand, people with 
high risk behaviour may be over-represented, increasing campaign testing prevalence. Most asympto-




Scientific evidence of the efficacy of triple combina-
tion antiretroviral therapy exists since 1996, but treat-
ment is expensive. General social security based ac-
cess in rich countries, and paid access for rich people 
in poor countries, created an ethically as well as medi-
cally justified demand for highly active antiretroviral 
therapy (HAART) in poor countries. The difference in 
treatment possibilities is especially visible in Africa, 
which carries the main burden of the epidemic. 
 HAART was introduced in the region of Adamawa 
in Cameroon from 2001, as part of the National 
HIV/AIDS Program subsidised by the WHO and other 
international organisations. A day hospital unit was 
opened and a therapeutic committee was formed at the 
Provincial hospital, one of the two hospitals in the 
town of Ngaoundere with roughly 250 000 inhabitants. 
A medically led Technical group has from 2001 orga-
nised a week of voluntary, free-of-charge HIV testing 
around the international AIDS day 1 December. A 
systematic pre-counselling was given by trained health 
personnel, and the test results were given in a post-
counselling session one week later. We wanted to 
study who came for testing, what they knew about 
HIV, how many came back for the results and who had 
a positive test. Based on the data we reflect upon 




MATERIAL AND METHOD 
 
The number of persons tested for each of the four con-
secutive years 2001-2004 was: 534, 866, 661 and 344, 
respectively. Because of problems with the testing 
procedures in 2001, the analyses presented here 
include data from the years 2002-2004 only. In 2002, 
the counselling sheets for 99 persons disappeared, and 
767 of the total 866 persons were included for further 
analyses. 
 A first negative test was accepted as a final result. 
A positive result was always checked by a second test, 
and if not concordance, by a third test performed at a 
Centre Pasteur laboratory in the town of Garoua, 275 
km away. From 2002, Determine® was used as a first 
test and Immuno-Comb® as the second test. The idea 
is to start with a highly sensitive test to have as few 
false negatives as possible, and confirm positive tests 
with a highly specific test to avoid false positives (1). 
 Data were recorded and analysed in SPSS 
(http://www.SPSS.com/). Chi square test was used for 
comparison between groups for categorical variables, 
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and t test for continuous variables. Logistic regression 
analyses were performed for assessing associations of 
HIV seropositivity with potential determinants. The fi-
nal logistic regression model was determined based on 
analyses of bivariate associations between seropositi-
vity and variables that could reasonably influence 
seropositivity, and on elimination of some variables 
not showing independent association in initial models. 
 Permission to transfer data from paper protocols 
and counselling forms to an anonymous data file was 
given by the provincial head of public health in 
Ngaoundere. A committee of ethics was in preparation 
at the provincial hospital but had not yet started func-
tioning in 2002. The Regional Committee for Medical 
Research Ethics in Western Norway (REK III) was 
consulted about a HIV therapy project using routine 
clinical data to improve quality. Based on their judge-
ment that this did not need approval of the Committee, 






The prevalence of HIV-seropositivity was 9.0% am-
ong all persons attending the campaign testing during 
the years 2002-04. In 2002, females being tested had a 
mean age of 25.6 years (95% confidence interval 24.7–
26.5), males 29.1 years (95% CI 28.2–30.0). Seroposi-
tive persons had a mean age of 30.0 years (95% CI 
28.1–31.9), and seronegative persons 27.3 years (95% 
CI 26.6–28.0). For each sex separately, the difference 
is significant for males (P = 0.001) but not for females. 
 Tables 1-3 show that seropositivity tended to in-
crease with female sex, increasing age and number of 
sex partners, and with less schooling. The last finding 
is strengthened by an inverse relationship between 
knowledge about HIV and seropositivity in both fe-
males and males (table 2). The number of sex partners 
reported the last five years was on average 2.5 for 
females (95% CI 2.2–2.8) and 4.9 for males (95% CI 
4.3–5.4). Seropositive persons reported a mean num-
ber of 4.9 sex partners (95% CI 3.7–6.1) and sero-
negative persons 3.7 (95% CI 3.4–4.1). For each sex 
separately, this difference is significant for females    
(P = 0.009) but not for males. 
 Females who came to voluntary testing had higher 
seropositivity than males throughout the years of cam-
paign testing (table 1). If seropositive, females tended 
to have had an earlier sex debut than males (P = 0.027) 
and females were more often unmarried than males   
(P = 0.008). Males had more partners also for the sero-
negative group (P<0.001). Seronegative males had a 
new partner last 4 months more often than sero-
negative females (P = 0.001) and tended to have had 
an earlier sex debut (P = 0.015) and report regular 
condom use more often than seronegative females      
(P = 0.002). 
 Males who are frequently on travel and females 
who sell sex are well known risk groups and are pro-
bably represented among males with mobile profes-
sions and unmarried females, especially those classi-
fied as unemployed (tables 1-2). Regular condom use 
was reported more frequently in seronegative than in 
seropositive persons although this relationship was not 
significant for each sex separately and in logistic reg-
ression models. 
 One of five persons tested never came back to 
know their result, but seropositivity in this group was 
not higher (table 1). There was no difference between 
age groups when it came to know the result. However, 
seropositive persons more often had kept to them-
selves that they had been tested (table 2). 
 One seronegative man was the only one who said 
he had had sex with men. One woman said she feared 
being seropositive because she knew her husband had 
had sex with men, and her test was positive. 
 
 
Table 1.  Seropositivity in relation to profession and communication of test results in HIV test campaigns during 2002-2004 for females 
(F) and males (M). 
 
 2002  2003  2004  2002-04 





























Profession                         
     Local work   75 12 16 188 22 12                   
     Mobile work a     1   0   0   32   8 25                   
     Unemployed b   96 26 27   25   2   8                   
     Students/pupils 145 10   7 195   2   1                   
     Unknown     4                        
Came to know the result                          
     Did come 245 35 14 362 26   7  231 25 11 335 17 5  127 15 12 147 6 4  1447 124  9 
     Did not come   76 13 17   84   9 11    36   5 14   60   3 5    51   6 12   27 1 4    334   37 11 
All persons tested and recorded* 321 48 15 446 35   8  267 30 11 395 20 5  178 21 12 174 7 4  1781 161  9 
Not recorded, not included in table   40 –    59 –                    99 –  
a Truck drivers, soldiers, police 
b Housewives, people looking for employment, retired persons 
* Relatively more females were seropositive, 2002: P=0.002, 2003: P<0.01, 2004: P<0.02 
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 In addition to the December campaign testing, a 
separate campaign aimed at university and college stu-
dents in February 2003 revealed only 10 cases of sero-
positivity among 310 students (table 4). During non-
campaign periods, altogether 1665 tests in 2003 and 
2828 tests in 2004 were performed at the day hospital 
at a subsidised price of approximately 1.5 USD paid 
by the patient. These tests were performed both in 
asymptomatic persons who wanted the test, and in per-
sons referred by health personnel on the basis of con-
sultations for symptoms. A high but unknown propor-
tion was initiated on clinical grounds. Approximately 
10-20% were performed free of charge in consenting 
asymptomatic pregnant women. The proportion of 
seropositive results was expectedly higher outside 
campaign periods (P<0.001 for both years). The pro-
portion of persons who did not come back for their 
results was also higher in non-campaign-tested persons 
(table 4). 
 From 2002, HIV positive persons were offered a 
contact with one of the hospital’s few lay HIV positive 
volunteers immediately after the post-counselling by 
health personnel. This offer has been accepted in more 
than half of the cases, although we have no exact 
figures and no evaluation of the value of such talks. 
All seropositive persons also got an appointment with 
a medical doctor one to two weeks later, but only a 
small proportion, perhaps 10-20 per cent, have come 
back for these appointments with laboratory examina-
tions and formal registration as an HIV patient. Again, 
we have no figures, but this seems different from peo-
ple who test positively on clinical grounds. They usu-
ally come back to see their referring health professio-




Table 2.  Characteristics of persons tested in 2002, in relation to seropositivity for females and males.* 
 
 Females (N = 321)  Males (N = 446) 
 Seropositive % P-value  Seropositive % P-value 
Schooling    <0.001     
    None 7 33   3 20  
    1-9 years 16 28   8 12  
    10+ years 23 11   22 7  
Marital status        <0.001 
    Married, monogamous 10 13   18 16  
    Married, polygamous 6 24   4 17  
    Not married 32 15   12 4  
Number of sex partners    0.004      0.010 
    0-1 12 9   2 3  
    2-3 12 12   15 11  
    4-9 16 29   9 6  
    10+ 2 29   7 15  
New partner last 4 months         
    Yes 3 16   1 2  
    No 11 6   4 2  
Age, sexual debut   0.003     
    <16 years of age 21 30   6 6  
    16-19  21 12   17 8  
    20+ 6 14   10 10  
Condom use**        
    Regular 4 9   5 5  
    Not regular or never 44 17   28 9  
Knowledge: cause of HIV   0.001    <0.001 
    Virus 13 9   9 4  
    Other cause  29 23   21 14  
Can explain seropos. vs. aids    0.012      0.007 
    Can explain 19 11   14 5  
    Cannot explain 25 21   17 13  
Confidence: Told about test    0.003    <0.001 
    To no one 6 43   8 20  
    To someone 28 13   13 5  
* Information available for 767 persons of the 876 tested. 
** Regular condom use was more frequent in seronegative than in seropositive persons (P=0.026), but for each 
sex separately, this difference was not significant. 
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Table 3.  Association between seropositivity and personal 
characteristics based on logistic regression analyses of data 
from 2002.* 
 
 Odds ratio** 95% CI 
Age in years (continuous) 1.03 1.0–1.06 
Sex  (female=1, male=2) 2.1 1.5–2.7 
Number of sex partners last 5 years 
(continuous) 
1.07 1.0–1.1 
Regular (=1) vs. not regular (=2) condom use 2.2 0.8–2.5 
Schooling (None=1, 1-8 yrs=2, >8yrs=3) 1.4 1.2–1.7 
* 151 persons with incomplete data were excluded 
** OR > 1 for increasing age, female sex, increasing number of 
partners, and less schooling. For condom use, OR 2.2 for not regular 




 From 2002, discordant tests and tests with un-
certain results have become exceptional. However, in 
spite of a very good control system at the local labora-
tory, one positive result was communicated to a sero-
negative person who had got two numbers because 
waiting time had made her leave and come back for 
testing. It was discovered because the shocked young 
woman claimed she was a virgin. Subsequent double 
testing was negative and the error found. During the 
2002 campaign, three lay HIV positive volunteers re-
tested themselves and one was found to be negative. 
She had falsely tested positively three years earlier and 
had no money for a second, confirmatory test, which 
she considered superfluous because she had suspected 





For the overall poor population in Ngaoundere and in 
most African countries in general, campaigns offering 
free-of-charge testing may be a good idea to promote 
knowledge about the HIV epidemic and to give people 
an opportunity to know their HIV status. Our study 
consistently confirms the important role of specific 
HIV knowledge as well as of education in general in 
preventing new cases of HIV. Pre- and post-
counselling is well organised in Ngaoundere and may 
contribute to better information. 
 A large proportion of the population still have no 
or little formal schooling. In a previous study in Ngao-
undere with a relatively high population representa-
tivity, it was found that half of all women in fertile age 
had no schooling at all, not counting choranic schools 
in this mixed Moslem-Christian population (2). In the 
HIV context, it tells that this is a vulnerable population 
where information and local initiative are important. 
The upstart of “the therapeutic era” should not be 
underestimated for what it gives in terms of hope and 
increased interest (3,4), however difficult it is to inte-
grate long-term treatment in a culture with a weak and 
often failing health structure (5). These cultural and 
structural difficulties are illustrated in the study by the 
high number of people not coming back for their re-
sults, and by the high number of newly diagnosed but 
mostly healthy-feeling HIV positive persons who do 
not come to their scheduled consultation with a medi-
cal doctor. Campaign testing more than clinically 
based testing increases the group of people who know 
they are seropositive but who do not receive post-test 
counselling and medical follow-up that might reduce 
their probability of spreading the infection. 
 Lack of ability to pay is a problem in this popula-
tion. Many persons coming for campaign testing say 
they would not have come during the year, when they 
have to pay a subsidised fee. Even if campaign testing 
is free of charge, the laboratory work-up and further 
follow-up for seropositive persons cost money, even if 
one omits the more expensive tests like viral load and 
some serological tests. CD4 is analysed locally and is 
less expensive. It is possible to follow patients through 
good clinical evaluations and a minimum of cheap 
blood tests, but doctors who are forced to practice in a 
very deprived and often lonely medical reality then 
receive little learning and stimulus to improve their cli-
nical practice. In Ngaoundere, an economic analysis of 
the patient’s possibilities to pay during the next two to 
three years always accompanies the clinical evaluation 
when the therapeutic committee takes a decision about 
starting therapy. Dramatically lowered drug prices 
have helped a high number of people, but regular 
payment is still beyond the means of most individuals. 
Many receive help from their extended family and are 
thus accepted for therapy. It is not only a question of 
HIV drugs, but also of prophylactic and therapeutic 
medication against opportunistic infections. It is pro-
bably difficult for Western people to imagine to what 




Table 4.  Seropositivity of HIV in data from campaigns and during clinically indicated testing in 2003-2004. 
 
 2003  2004 
 Females Males  Females Males 
 n 
Sero- 






positive % n 
Sero- 
positive % 
December campaign for all 267 30 11 395 20   5    178   21 12   174     7   4 
Student campaign, February    84     5   6 226   5   2  –   –   
Regular testing rest of the year 961 206 21 745 151 20  1525 441 29 1303 262 20 
Did not come for the result  101   17 17 108 13 12    182   39 21   112   18 16 
THE VALUE OF HIV CAMPAIGN TESTING  163 
are employed – are economically poor, and how it 
affects their daily life and their possibility to buy non-
necessities (6). 
 As a group, the campaign tested persons are much 
better educated than the average population. The sepa-
rate student campaign as well as the analysis of profes-
sions in the 2002 campaign shows that this particular 
group has relatively little seropositivity compared with 
other people being tested. It might thus seem probable 
that seropositivity in the adult population is higher 
than the 9.0% during the last three campaign years. 
WHO classifies Cameroon as a high burden country 
with an estimated HIV prevalence of 6.9% for the age 
group 15-49 years at the end of 2003 (7). A more 
recent survey in 2004 based on 11400 households has 
given a lower estimate of 5.5% for the whole country 
(Daniel Salpou, personal communication). Possibly the 
campaigns actually attract a segment of the population 
having some suspicion that they might be seropositive. 
The finding that relatively more seropositive persons 
had kept their testing for themselves may give some 
support to such a hypothesis. It is not unreasonable 
that more educated persons reflect more upon current 
public HIV information. This could explain that cam-
paign seropositivity even in a better educated segment 
of the population could be higher than national figures 
based on surveys. National estimates used to be higher 
for the Adamawa province than for the rest of the 
country, and this is still so in the 2004 survey with a 
prevalence of 6.9% (Daniel Salpou, personal commu-
nication). 
 The HIV-prophylactic effect of condom use is well 
established. In the present study, a higher seropositi-
vity for non-regular users is suggested but did not 
reach statistical significance in the logistic regression 
model (table 3). The effect may have been weakened 
in our study if people with more partners tend to be 
more regular condom users. Such a hypothesis is sup-
ported by a higher proportion of regular condom users 
among seronegative males than among seronegative 
females, and the higher number of sex partners the last 
5 years for males. The importance of reducing the 
number of sex partners is confirmed in this study. 
 The higher seropositivity of females is very consis-
tent and probably reflects more than a selection bias 
due to differential attendance at the campaign testing. 
The higher seropositivity in unmarried females and in 
females having had an early sex debut strengthens the 
impression of an HIV vulnerable female population, 
and females are also contaminated at a younger age. 
Female biological as well as social vulnerability for 
HIV is well known (8,9). Extreme examples of the 
latter during the campaigns include one woman being 
tested after mass rape by soldiers in a war area in a 
neighbouring country, and a female university student 
reporting that she entertained a relationship to a mar-
ried man because this was the only way she could pay 
for her studies. 
 Being HIV positive is clearly associated with great 
stigma, in this study suggested by a higher rate of sero-
positive people keeping the testing results for them-
selves. There are few voluntary counsellors in the local 
group of HIV positive people, but those who partici-
pate in the education of the population and in support 
of fellow HIV positive persons may have a significant 





HIV campaigns including testing may stimulate inte-
rest and knowledge about HIV, which is important to 
lower HIV incidence. Campaigns have problems in att-
racting less educated persons, and most asymptomatic 
persons receiving a positive test result did not come 
back for medical follow-up. The HIV vulnerability of 
females was confirmed. Our results indicate that all 
programmes for HIV-testing and necessary follow-up 
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